Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Sep 25;33(173):240096.
doi: 10.1183/16000617.0096-2024. Print 2024 Jul.

Bronchiectasis in Asia: a review of current status and challenges

Hayoung Choi  1 , Jin-Fu Xu  2   3 , Sanjay H Chotirmall  4   5 , James D Chalmers  6 , Lucy C Morgan  7 , Raja Dhar  8
Affiliations
Review

Bronchiectasis in Asia: a review of current status and challenges

Hayoung Choi et al. Eur Respir Rev. .

Abstract

Recent bronchiectasis studies from large-scale multinational, multicentre registries have demonstrated that the characteristics of the disease vary according to geographic region. However, most perspectives on bronchiectasis are dominated by data from Western countries. This review intends to provide an Asian perspective on the disease, focusing on the established registries in India, Korea and China. Asian patients with bronchiectasis are less likely to show female predominance and experience exacerbations, are more likely to be younger, have milder disease, and have fewer options for guideline-recommended treatment than those living in other global regions. Furthermore, Asian bronchiectasis patients demonstrate different comorbidities, microbiological profiles and unique endophenotypes, including post-tuberculosis and dry bronchiectasis. Notably, each Asian region reveals further geographic variations and inter-patient differences. Future studies are warranted to better characterise Asian patients with bronchiectasis.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: H. Choi reports grant from the Basic Science Research Program of the Korean Ministry of Education (grant no. 2021R1I1A3052416); and consulting and lecture fees from Boryung Pharmaceutical Co., Ltd. and Kolon Pharma. J-F. Xu reports leadership or fiduciary roles in other boards, societies, committees, or advocacy groups (unpaid) with the Shanghai Medical Association, Chinese Thoracic Society, and Chinese Association of Chest Physicians. S.H. Chotirmall has served on advisory boards for CSL Behring, Pneumagen Ltd and Boehringer Ingelheim, on data monitoring boards for Inovio Pharmaceuticals and Imam Abdulrahman Bin Faisal University, and has received personal fees from AstraZeneca and Chiesi Farmaceutici, all unrelated to this work J.D. Chalmers reports grants or contracts from AstraZeneca, Boehringer Ingelheim, Genentech, Gilead Sciences, GlaxoSmithKline, Grifols, Insmed, LifeArc and Novartis; and consulting fees from AstraZeneca, Chiesi, GlaxoSmithKline, Insmed, Grifols, Novartis, Boehringer Ingelheim, Pfizer, Janssen, Antabio and Zambon. L.C. Morgan reports payment or honoraria for speakers’ bureau from Boehringer Ingelheim, AstraZeneca and Insmed, and educational events from GSK Pharmaceutical and AstraZeneca, all unrelated to this work. In addition, L.C. Morgan reports a leadership or fiduciary role in other boards, societies, committees, or advocacy groups (unpaid) as Chair of the Lung Foundation Australia. R. Dhar reports grants from GSK Pharmaceutical and Glenmark and Thorasis; and lecture fees from Cipla Ltd., Lupin Respira, Glenmark, Abbott, Sanofi and AstraZeneca.

Figures

FIGURE 1
FIGURE 1
Profiles of Asian bronchiectasis. BMI: body mass index; P.: Pseudomonas; TB: tuberculosis.
See this image and copyright information in PMC

Comment in

  • doi: 10.1183/16000617.0124-2024

Similar articles

  • Baseline characteristics of patients in the Chinese Bronchiectasis Registry (BE-China): a multicentre prospective cohort study.
    Xu JF, Zheng HZ, Lu HW, Wang LW, Wu B, Lv XD, Luo H, Feng J, Li YY, Liu L, Jia JG, Mo WQ, Gu HY, Jiang JB, Wang DX, Wang B, Li L, Yuan Z, Li W, Xie M, Jie ZJ, Fan XY, Li D, Tian X, Zhang M, Guan WJ, Fan H, Song YL, He J, Chu DJ, Du CL, Zhang JQ, Cao C, Qu JM, Chalmers JD; BE-China Registry Investigators. Xu JF, et al. Lancet Respir Med. 2025 Feb;13(2):166-176. doi: 10.1016/S2213-2600(24)00364-3. Epub 2025 Jan 10. Lancet Respir Med. 2025. PMID: 39805296
  • Bronchiectasis in India: results from the European Multicentre Bronchiectasis Audit and Research Collaboration (EMBARC) and Respiratory Research Network of India Registry.
    Dhar R, Singh S, Talwar D, Mohan M, Tripathi SK, Swarnakar R, Trivedi S, Rajagopala S, D'Souza G, Padmanabhan A, Baburao A, Mahesh PA, Ghewade B, Nair G, Jindal A, Jayadevappa GDH, Sawhney H, Sarmah KR, Saha K, Anantharaj S, Khanna A, Gami S, Shah A, Shah A, Dutt N, Garg H, Vyas S, Venugopal K, Prasad R, Aleemuddin NM, Karmakar S, Singh V, Jindal SK, Sharma S, Prajapat D, Chandrashekaria S, McDonnell MJ, Mishra A, Rutherford R, Ramanathan RP, Goeminne PC, Vasudev P, Dimakou K, Crichton ML, Jayaraj BS, Kungwani R, Das A, Sawhney M, Polverino E, Torres A, Gulecha NS, Shteinberg M, De Soyza A, Mangala A, Shah P, Chauhan NK, Jajodia N, Singhal A, Batra S, Hasan A, Limaye S, Salvi S, Aliberti S, Chalmers JD. Dhar R, et al. Lancet Glob Health. 2019 Sep;7(9):e1269-e1279. doi: 10.1016/S2214-109X(19)30327-4. Lancet Glob Health. 2019. PMID: 31402007
  • Epidemiology of bronchiectasis.
    Nigro M, Laska IF, Traversi L, Simonetta E, Polverino E. Nigro M, et al. Eur Respir Rev. 2024 Oct 9;33(174):240091. doi: 10.1183/16000617.0091-2024. Print 2024 Oct. Eur Respir Rev. 2024. PMID: 39384303 Free PMC article. Review.
  • KMBARC registry: protocol for a multicentre observational cohort study on non-cystic fibrosis bronchiectasis in Korea.
    Lee H, Choi H, Sim YS, Park S, Kim WJ, Yoo KH, Lee SJ, Kim TH, Yang B, Jeong I, Um SJ, Kim DK, Lee JH, Kwon BS, Cho YJ, Park HY, Lee CH, Rhee CK, Lee SH, Na JO, Jang AS, Jung JY, Ra SW, Lee JH, Kim SH, Kim C, Kim Y, Lee CY, Kim HK, Lee JS, Lee SW, Oh YM; KMBARC. Lee H, et al. BMJ Open. 2020 Jan 19;10(1):e034090. doi: 10.1136/bmjopen-2019-034090. BMJ Open. 2020. PMID: 31959610 Free PMC article.
  • Exacerbations of bronchiectasis.
    De Angelis A, Johnson ED, Sutharsan S, Aliberti S. De Angelis A, et al. Eur Respir Rev. 2024 Jul 24;33(173):240085. doi: 10.1183/16000617.0085-2024. Print 2024 Jul. Eur Respir Rev. 2024. PMID: 39048130 Free PMC article. Review.
See all similar articles

Cited by

References

    1. Chalmers JD, Chang AB, Chotirmall SH, et al. . Bronchiectasis. Nat Rev Dis Primers 2018; 4: 45. doi:10.1038/s41572-018-0042-3 - DOI - PubMed
    1. O'Donnell AE. Bronchiectasis – a clinical review. N Engl J Med 2022; 387: 533–545. doi:10.1056/NEJMra2202819 - DOI - PubMed
    1. Aksamit TR, O'Donnell AE, Barker A, et al. . Adult patients with bronchiectasis: a first look at the US bronchiectasis research registry. Chest 2017; 151: 982–992. doi:10.1016/j.chest.2016.10.055 - DOI - PMC - PubMed
    1. Chalmers JD. Bronchiectasis from 2012 to 2022. Clin Chest Med 2022; 43: 1–6. doi:10.1016/j.ccm.2021.12.001 - DOI - PubMed
    1. Chalmers JD, Aliberti S, Polverino E, et al. . The EMBARC European Bronchiectasis Registry: protocol for an international observational study. ERJ Open Res 2016; 2: 00081-2015. doi:10.1183/23120541.00081-2015 - DOI - PMC - PubMed

LinkOut - more resources